ATI (NYSE:ATI) Bolsa

ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several the majority of end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.

Allegheny Technologies

ATI Inc

ATLANTIS GAMING CORP by Atlantis Gaming Corporation

Atlantis Gaming Corp

Archimedes Tech SPAC Partners II Co. - Ordinary Shares

Archimedes Tech SPAC Partners II Co

Archimedes Tech SPAC Partners II Co. - Unit

Archimedes Tech SPAC Partners II Co. - Warrant

ATI PHYSICAL THERAPY A by ATI Physical Therapy, Inc.

ATI Physical Therapy Inc

ATI Physical Therapy Inc Warrants (10/08/2027)

ATI Networks Inc

ANALYTIXINSIGHT INC by Analytixinsight Inc

AnalytixInsight Inc

IperionX Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPX#NASDAQ">IPX</a>) shares surged Thursday after the company <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/g45790807/iperionx-awarded-u-s-department-of-defense-sbir-phase-iii-contract-for-up-to-us-99m" rel="noreferrer noopener">secured a major U.S. Department of Defense</a> contract to supply domestically produced titanium parts for military use.
The $99 million Small Business Innovation Research (SBIR) Phase III Indefinite Delivery, Indefinite Quantity (IDIQ) agreement enables the Pentagon to order titanium components directly from IperionX.
The contract permits U.S. defense agencies to commission task-specific orders as part of the &#8220;Low-Cost Domestic Titanium for Defense Applications&#8221; effort.
Early task orders will involve high-performance titanium fasteners manufactured at IperionX&#8217;s Virginia campus using proprietary technologies. The project supports skilled local jobs while advancing U.S. defense readiness.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/05/45667868/top-2-materials-stocks-that-are-ticking-portfolio-bombs" rel="noreferrer noopener">Top 2 Materials Stocks That Are Ticking Portfolio Bombs</a>
The agreement aligns with federal priorities to boost the supply of strategic materials from domestic sources. Future task orders could include advanced aerospace parts, positioning IperionX as a long-term supplier for military-grade titanium.
&#8220;Securing this Phase III contract is a pivotal milestone for IperionX,&#8221; said Anastasios (Taso) Arima, the company&#8217;s CEO. &#8220;It validates the performance of our technologies and underscores the Department of Defense&#8217;s commitment to reshore an all-American titanium supply chain.&#8221;
Relevant ETFs include SPDR S&amp;P Aerospace &amp; Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XAR#NYSE">XAR</a>) and iShares U.S. Aerospace &amp; Defense ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITA#BATS">ITA</a>).
Price Action: IPX shares are trading 23.79% higher at $30.23 at Thursday&#8217;s last check.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/commodities/25/06/45774621/lucid-strikes-deal-to-use-us-sourced-graphite-in-future-evs-starting-2028" target="_blank" rel="noreferrer noopener">Lucid Strikes Deal To Use US-Sourced Graphite In Future EVs Starting 2028</a></li>
</ul>

News

Contracts

IperionX Rockets 23% After Securing $99M Defense Contract For Domestic Titanium

ATI Signs Multi-Year Agreement With Airbus To Supply Titanium Plate, Sheet And Billet

KeyBanc Capital Markets analyst Philip Gibbs downgraded ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) <a href="https://www.benzinga.com/quote/ATI/analyst-ratings" target="_blank" rel="noreferrer noopener">from Overweight to Sector Weight</a>.
At the beginning of May, ATI reported first-quarter results, with aerospace and defense sales of $754 million, <a href="https://www.benzinga.com/pressreleases/25/05/n45130989/ati-announces-first-quarter-2025-results" target="_blank" rel="noreferrer noopener">representing 66% of sales.</a>
Gibbs has increased ATI&#8217;s 2025 estimates, citing stronger-than-expected demand in the aerospace engine and defense markets, and has also introduced projections for 2026 based on continued growth in those sectors.
While the analyst continues to view ATI as a solid long-term cyclical growth story with meaningful exposure to aerospace and defense, the analyst notes that many near-term catalysts — such as multiple expansion following the April upgrade — have &#8220;quickly played out.&#8221;
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/05/45523994/raytheon-boosts-us-military-defense-with-advanced-threat-tracking-radar" rel="noreferrer noopener">Raytheon Boosts US Military Defense With Advanced Threat-Tracking Radar</a>
As a result, despite the positive demand outlook, Gibbs sees a more balanced risk-reward profile in the near term.
Following the quarterly results, the analyst raised the 2025 EPS estimate to $3.07 from $2.82, aligning with ATI&#8217;s guidance of $2.87–$3.09.
Gibbs now projects EBITDA of $835 million versus prior $814 million, near the high end of the company&#8217;s $800 million–$840 million range, which remains conservative.
The company lifted its aerospace engine growth outlook to 15%–20%-plus year-over-year from 9%-plus, reflecting a richer product mix, while maintaining its low-single-digit airframe growth view, with lower titanium volumes offset by better pricing and mix.
Concerns about Russia&#8217;s potential return to the titanium market in a de-escalation scenario were eased by ATI&#8217;s new $1 billion airframe supply deal with&nbsp;&nbsp;Airbus SE (OTC:<a class="ticker" href="https://www.benzinga.com/stock/EADSY#OTC">EADSY</a>), which runs from 2026 to 2030.
Some limited pressure is expected from softer demand in China for power generation and nuclear-related sales due to trade tensions, but tariffs now appear more manageable.
Gibbs also raised 2025 free cash flow to equity to $309 million from $297 million, driven by higher EBITDA, with net capex of $240 million based on gross capex of $270 million and $30 million in customer reimbursements.
The analyst established a 2026E EPS of $3.63 and EBITDA of $937 million.
ATI Price Action: ATI shares are trading lower by 1.96% to $75.09 at publication on Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/25/05/45503979/5-stocks-about-to-short-squeeze-as-market-rebounds" target="_blank" rel="noreferrer noopener">5 Stocks About To Short Squeeze As Market Rebounds</a></li>
</ul>
Photo: T. Schneider via Shuttestock

Equities

Markets

Analyst Ratings

Movers

Trading Ideas

General

European Aeronautic Defence And Space Unsponsored

EADSY

ATI Downgrade: Analyst Cautious As Near-Term Catalysts 'Have Quickly Played Out'

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Keybanc analyst Philip Gibbs downgraded the rating for ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) from Overweight to Sector Weight. ATI shares closed at $76.58 on Monday. <a href="https://www.benzinga.com/quote/ATI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. analyst Arthur He downgraded Prime Medicine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>) from Buy to Neutral. Prime Medicine shares closed at $1.3350 on Monday. <a href="https://www.benzinga.com/quote/PRME/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital analyst Yun Kim downgraded MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) from Buy to Hold and lowered the price target from $350 to $190. MongoDB shares closed at $189.01 on Monday. <a href="https://www.benzinga.com/quote/AFRMDBM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Eric Joseph downgraded the rating for Prime Medicine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>) from Overweight to Neutral. Prime Medicine shares closed at $1.3350 on Monday. <a href="https://www.benzinga.com/quote/PRME/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Michael Sison downgraded the rating for Westlake Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) from Overweight to Equal-Weight and cut the price target from $95 to $76. Westlake shares closed at $79.94 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratingsWLK">See how other analysts view this stock.</a></li>
</ul>
Considering buying MDB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="563" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246-1024x563.png" alt="" class="wp-image-921180" style="width:670px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246-1024x563.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246-300x165.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246-768x422.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246.png 1123w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45511338/home-depot-toll-brothers-and-3-stocks-to-watch-heading-into-tuesday">Home Depot, Toll Brothers And 3 Stocks To Watch Heading Into Tuesday</a> </li>
</ul>
Photo via Shutterstock

Downgrades

Pre-Market Outlook

PRME

This MongoDB Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Keybanc analyst Philip Gibbs downgrades ATI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) from Overweight to Sector Weight.

Keybanc Downgrades ATI to Sector Weight

These mid-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>Pony AI Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) shares were up 48.36% after the company reportedly said it is getting closer to profitability and can build its <a href="https://www.benzinga.com//node/45049945" target="_blank" rel="noreferrer noopener">autonomous driving system for less</a>.</li>
<li>Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) stock rocketed 45.32% after the company announced a collaboration with Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) to offer a bundled package of all dose <a href="https://www.benzinga.com//node/45074872" target="_blank" rel="noreferrer noopener">strengths of Wegovy on its platform</a>. B of A Securities analyst raised the price <a href="https://www.benzinga.com/quote/hims/analyst-ratings" target="_blank" rel="noreferrer noopener">forecast from $22 to $26</a>.</li>
<li>ODDITY Tech Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) shares surged 42.96% after the company reported better-than-expected first-quarter financial results, raised its FY25 guidance, and issued <a href="https://www.benzinga.com//node/45111584" target="_blank" rel="noreferrer noopener">second-quarter guidance above estimates</a>. Analysts raised price <a href="https://www.benzinga.com/quote/ODD/analyst-ratings" target="_blank" rel="noreferrer noopener">forecasts on the stock</a>.</li>
<li>Metsera, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSR#NASDAQ">MTSR</a>) stock escalated by 38.42% last week.</li>
<li>CG Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGON#NASDAQ">CGON</a>) stock increased 29.86% after the company announced that cretostimogene grenadenorepvec monotherapy data was presented at the American <a href="https://www.benzinga.com//node/45043205" target="_blank" rel="noreferrer noopener">Urological Association Annual Meeting</a>. Some analysts initiated coverage/ <a href="https://www.benzinga.com/quote/cgon/analyst-ratings" target="_blank" rel="noreferrer noopener">boosted the price forecast</a>.</li>
<li>Kiniksa Pharmaceuticals, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNSA#NASDAQ">KNSA</a>) shares upped 29.42% after raising <a href="https://www.benzinga.com//node/45063476" target="_blank" rel="noreferrer noopener">its FY25 sales guidance</a>.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) stock rose 27.34%.</li>
<li>Frontdoor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTDR#NASDAQ">FTDR</a>) shares were up 25.44% last week after the company reported better-than-expected first-quarter financial results and raised its FY25 <a href="https://www.benzinga.com//node/45130988" target="_blank" rel="noreferrer noopener">sales outlook</a>.</li>
<li>ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) stock increased 25.39% after it reported better-than-expected quarterly financial results and raised its <a href="https://www.benzinga.com//node/45130989" target="_blank" rel="noreferrer noopener">FY25 adjusted EPS guidance</a>.</li>
<li>Perdoceo Education Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRDO#NASDAQ">PRDO</a>) stock rose 23.72% after it <a href="https://www.benzinga.com//node/45149554" target="_blank" rel="noreferrer noopener">reported first-quarter results</a>.</li>
<li>iRhythm Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>) stock jumped 23.71% after it reported better-than-expected first-quarter results and <a href="https://www.benzinga.com//node/45149802" target="_blank" rel="noreferrer noopener">raised its FY25 sales guidance</a>.</li>
</ol>
Photo by Tada Images via Shutterstock

Mid Cap

CGON

FTDR

Hims & Hers Health, Inc. Class A Common Stock

HIMS

IRTC

KNSA

MTSR

PONY

PRDO

Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?

U.S. stocks were higher, with the Dow Jones index gaining around 400 points on Thursday.
Shares of CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) rose sharply during Thursday's session after the company reported better-than-expected first-quarter results and <a href="https://www.benzinga.com/quote/CVS/earnings">raised FY25 EPS guidance</a>.
CVS Health reported first-quarter sales of $94.59 billion on Thursday, beating the consensus of $93.64 billion. Total revenues increased 7% year over year, driven by revenue growth across all segments.
CVS Health posted adjusted EPS of $2.25 for Q1, a sharp rise from $1.31 a year earlier and well above Wall Street&#8217;s $1.70 estimate.
CVS Health shares jumped 6.5% to $71.11 on Thursday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Cantor Equity Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEP#NASDAQ">CEP</a>) surged 28% to $53.98.</li>
<li>E2open Parent Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETWO#NASDAQ">ETWO</a>) shares jumped 26.4% to $2.4901.</li>
<li>CommScope Holding Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COMM#NASDAQ">COMM</a>) gained 24.4% to $4.6550 following better-than-expected quarterly earnings.</li>
<li>MediaAlpha, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAX#NYSE">MAX</a>) rose 19.7% to $10.06 following strong quarterly sales.</li>
<li>Lotus Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOT#NASDAQ">LOT</a>) gained 19.6% to $1.9500.</li>
<li>Advanced Energy Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEIS#NASDAQ">AEIS</a>) rose 16.7% to $113.72 after the company reported better-than-expected first-quarter financial results and issued second-quarter sales guidance above estimates. Additionally, Needham maintained a Buy rating on the stock and Baird maintained an Outperform rating.</li>
<li>MYR Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYRG#NASDAQ">MYRG</a>) gained 16.2% to $142.09 following upbeat quarterly earnings.</li>
<li>CONMED Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNMD#NYSE">CNMD</a>) rose 16.1% to $57.01 after the company reported better-than-expected first-quarter financial results and raised its FY25 guidance.</li>
<li>CoreWeave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) gained 15.3% to $47.60.</li>
<li>Chart Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTLS#NYSE">GTLS</a>) rose 14.2% to $154.11 after the company reported better-than-expected first-quarter adjusted EPS results and issued FY25 adjusted EPS guidance above estimates. Also, the company issued FY25 sales guidance with its midpoint above estimates.</li>
<li>TTM Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTMI#NASDAQ">TTMI</a>) gained 13.4% to $22.70 after the company reported better-than-expected first-quarter financial results and issued second-quarter guidance above estimates.</li>
<li>Frontdoor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTDR#NASDAQ">FTDR</a>) rose 13.3% to $46.56 after the company reported better-than-expected first-quarter financial results and raised tis FY25 sales guidance above estimates.</li>
<li>Quanta Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWR#NYSE">PWR</a>) gained 12.4% to $329.11 after the company reported better-than-expected first-quarter financial results and raised its FY25 guidance with its midpoint above estimates.</li>
<li>ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) rose 12% to $60.87 after the company reported better-than-expected quarterly financial results and raised its FY25 adjusted EPS guidance.</li>
<li>Carrier Global Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARR#NYSE">CARR</a>) gained 10.4% to $69.07 after the company reported better-than-expected first-quarter financial results and raised its FY25 guidance.</li>
<li>Vertiv Holdings Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>) rose 9.7% to $93.67.</li>
<li>Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) gained 9.6% to $433.29 following strong quarterly earnings.</li>
<li>MasTec, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTZ#NYSE">MTZ</a>) rose 8.2% to $137.75.</li>
<li>CNH Industrial N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNH#NYSE">CNH</a>) gained 8.2% to $12.52 following quarterly results.</li>
<li>Comfort Systems USA, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIX#NYSE">FIX</a>) jumped 7.4% to $427.31.</li>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) gained 6.4% to $260.16.</li>
<li>Hyatt Hotels Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/H#NYSE">H</a>) rose 6.2% to $119.61 following upbeat results.</li>
<li>Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) gained 5.6% to $580.00 following strong quarterly results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/05/45135511/how-to-earn-500-a-month-from-apple-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Apple Stock Ahead Of Q2 Earnings</a> </li>
</ul>
Photo via Shutterstock

Earnings

AEIS

CARR

CNMD

COMM

CRWV

CVNA

ETWO

GTLS

MSFT

MYRG

TTMI

CVS Health Posts Better-Than-Expected Earnings, Joins CommScope, Microsoft, Meta, Chart Industries, And Other Big Stocks Moving Higher On Thursday

WIIM

ATI shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 adjusted EPS guidance.

Guidance

CORRECTION: ATI Sees Q2 Adj EPS $0.67-$0.73 vs $0.68 Est; Sees Adj. EBITDA  $195M-$205M

ATI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) raises FY2025 Adj EPS guidance from $2.80-$3.00 to $2.87-$3.09 vs $2.86 analyst estimate..

ATI Raises FY2025 Adj EPS Guidance from $2.80-$3.00 to $2.87-$3.09 vs $2.86 Est

ATI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of $0.59 by 22.03 percent. This is a 50 percent increase over earnings of $0.48 per share from the same period last year. The company reported quarterly sales of $1.14 billion which beat the analyst consensus estimate of $1.09 billion by 4.96 percent. This is a 9.72 percent increase over sales of $1.04 billion the same period last year.

Earnings Beats

ATI Q1 Adj. EPS $0.72 Beats $0.59 Estimate, Sales $1.14B Beat $1.09B Estimate

AAMI

AAPL

ABNB

ACCO

ADPT

AGCO

AGIO

ALHC

ALKS

ALNY

ALSN

AMGN

AMWL

AMZN

APLE

APTV

ARDX

ARVN

ASND

ASPS

ASUR

ATEC

ATEN

AXTI

BBAI

BIIB

BJRI

BLDR

BMRN

BOOM

BPMC

BRFH

CABO

CART

CERS

CMLS

COHN

COHU

COLM

COOK

CRAI

CTRE

CUBE

CWST

DBRG

DINO

DSGR

DUOL

DXCM

ECVT

ELME

Earnings Scheduled For May 1, 2025

ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) shares are trading higher on Wednesday after KeyBanc Capital Markets analyst Philip Gibbs upgraded it from Sector Weight to Overweight, <a target="_blank" href="https://www.benzinga.com/quote/ATI/analyst-ratings" rel="noreferrer noopener">with a price forecast of $55</a>.
The analyst says that although the FY25 earnings estimate is not revised, he anticipates that ATI&#8217;s guidance will incorporate sufficient offsetting factors to support its existing range of $2.80-$3.00.
Gibbs writes that the positive factors include an expectation of stronger and more consistent operational performance following issues in the second half of 2024 and a modest engine aftermarket growth forecast of +6% year-over-year (vs. some expectations of +15%-35% year-over-year).
See Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44962716/americans-rush-to-buy-cars-ahead-of-tariff-price-hikes-fed-beige-book-shows">Americans Rush To Buy Cars Ahead Of Tariff Price Hikes, Fed Beige Book Shows</a>
Potential negative factors include tariff effects, which the analyst says are unlikely to materialize until later in the year (if at all). ATI may also face a slowdown in airframe titanium sales (estimated -4% year-over-year in 2025).
Apart from this, the analyst says that he does not foresee the recent USW contract negotiations to have a significant impact on 2025, as there were no formal work stoppages.
Gibbs writes that he is holding off on establishing the 2026 estimates for the time being.
The 2025 earnings estimate does not currently include any profit impacts related to tariffs, as increased costs could be offset by higher sales/surcharges, adds the analyst.
For the medium term, the analyst expects ATI to gain from the ongoing multi-year increase in original equipment (OE) aerospace and defense (A&amp;D) ramp-up, increased business with Airbus and Pratt &amp; Whitney, and a strong aerospace aftermarket.
Further, the analyst adds that the Dallas-based company has strategically positioned itself to capitalize on greater opportunities in the defense sector for 2024-2025, including new contracts and applications.
In a separate release, the company disclosed that its employees have ratified a new six-year labor agreement <a href="https://www.benzinga.com/pressreleases/25/04/n44946353/ati-employees-ratify-new-six-year-agreement" target="_blank" rel="noreferrer noopener">with the United Steelworkers</a>. 
The company plans to release the first quarter 2025 earnings <a href="https://www.benzinga.com/earnings" target="_blank" rel="noreferrer noopener">results on May 1</a>.
Price Action: ATI shares are up 10.63% at $50.46 at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43776255/this-analyst-with-87-accuracy-rate-sees-more-than-50-upside-in-trade-desk-here-are-5-stock-picks-for-last-week-from-wall-streets-most-accurate-analysts" target="_blank" rel="noreferrer noopener">This Analyst With 87% Accuracy Rate Sees More Than 50% Upside In Trade Desk &#8211; Here Are 5 Stock Picks</a></li>
</ul>
Image: Shutterstock

Upgrades

ATI Upgrade: Analyst Weighs Strong Aftermarket, OE Ramp Against Tariff Risks And Airframe Slowdown

ATI shares are trading higher after Keybanc upgraded the stock from Sector Weight to Overweight and announced a price target of $55. Additionally, the company announced it has ratified a new six-year labor agreement with the United Steelworkers.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Keybanc analyst Philip Gibbs upgraded the rating for ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) from Sector Weight to Overweight and announced a $55 price target. ATI shares closed at $45.61 on Tuesday. <a href="https://www.benzinga.com/quote/ati/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Ronald Josey upgraded Lithia Motors, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAD#NYSE">LAD</a>) from Neutral to Buy but lowered the price target from $415 to $375. Lithia Motors shares closed at $295.45 on Tuesday. <a href="https://www.benzinga.com/quote/lad/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Redburn Atlantic analyst Harry Bartlett upgraded the rating for American Express Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) from Sell to Neutral but slashed the price target from $270 to $255. American Express shares closed at $252.42 on Tuesday. <a href="https://www.benzinga.com/quote/axp/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird analyst Peter Arment upgraded Lockheed Martin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) from Neutral to Outperform and maintained the price target of $540. Lockheed Martin shares closed at $462.08 on Tuesday. <a href="https://www.benzinga.com/quote/lmt/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>William Blair analyst Brian Drab upgraded the rating for Valmont Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) from Market Perform to Outperform. Valmont Industries shares closed at $278.28 on Tuesday.  <a href="https://www.benzinga.com/quote/vmi/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying LMT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="581" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/23090843/image-135-1024x581.png" alt="" class="wp-image-884169" style="width:609px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/23090843/image-135-1024x581.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/23090843/image-135-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/23090843/image-135-768x435.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/23090843/image-135.png 1120w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44920101/top-2-tech-and-telecom-stocks-you-may-want-to-dump-this-quarter">Top 2 Tech And Telecom Stocks You May Want To Dump This Quarter</a> </li>
</ul>
Photo via Shutterstock

This Lockheed Martin Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

DALLAS, April 23, 2025 /PRNewswire/ -- ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) announced its employees have ratified a new six-year labor agreement with the United Steelworkers (USW).&nbsp;
"We are pleased to have reached agreement with the USW for our Specialty Rolled Products employees at our Western Pennsylvania and Lockport, New York, facilities," said Kimberly A. Fields, ATI President and CEO.&nbsp;&nbsp;
The new agreement delivers a competitive wage and benefit package to nearly 1,000 represented employees, covering a six-year term through February 28, 2031. "This contract drives stability and consistency, enabling us to work together to serve our customers and reward our team," said Fields.

ATI Announces Its Employees Have Ratified A New Six-Year Labor Agreement With the United Steelworkers

Keybanc analyst Philip Gibbs upgrades ATI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) from Sector Weight to Overweight and announces $55 price target.

Price Target

Keybanc Upgrades ATI to Overweight, Announces $55 Price Target

In the latest quarter, 4 analysts provided ratings for ATI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for ATI, revealing an average target of $77.5, a high estimate of $81.00, and a low estimate of $73.00. Marking an increase of 2.99%, the current average surpasses the previous average price target of $75.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1745269220_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of ATI among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Josh Sullivan &#x7C;Benchmark &#x7C;Maintains &#x7C;Buy &#x7C; $81.00&#x7C;$81.00 &#x7C; 
&#x7C;Josh Sullivan &#x7C;Benchmark &#x7C;Raises &#x7C;Buy &#x7C; $81.00&#x7C;$80.00 &#x7C; 
&#x7C;David Strauss &#x7C;Barclays &#x7C;Raises &#x7C;Overweight &#x7C; $75.00&#x7C;$70.00 &#x7C; 
&#x7C;Charles Minervino &#x7C;Susquehanna &#x7C;Raises &#x7C;Positive &#x7C; $73.00&#x7C;$70.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to ATI. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of ATI compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of ATI's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into ATI's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ATI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on ATI analyst ratings.</a>
<h2>About ATI</h2>
ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several the majority of end markets, including the aerospace &amp; defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.
<h3>ATI: A Financial Overview</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Positive Revenue Trend: Examining ATI's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 10.22% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.
Net Margin: ATI's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 11.69%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): ATI's ROE stands out, surpassing industry averages. With an impressive ROE of 7.53%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): ATI's ROA stands out, surpassing industry averages. With an impressive ROA of 2.66%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: ATI's debt-to-equity ratio surpasses industry norms, standing at 1.02. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: What Are They?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where ATI Stands With Analysts

Benchmark analyst Josh Sullivan reiterates ATI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) with a Buy and maintains $81 price target.

Reiteration

Benchmark Reiterates Buy on ATI, Maintains $81 Price Target

In the current session, ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) is trading at $48.41, after a 0.51% drop. Over the past month, the stock decreased by 8.70%, and in the past year, by 11.60%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1744315226_0.png" alt="Past Year Chart" />

<h3>A Look at ATI P/E Relative to Its Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 42.71 in the Metals &amp; Mining industry, ATI Inc. has a lower P/E ratio of 19.08. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1744315226_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Price Over Earnings Overview: ATI

Press Releases

ATI CFO Don Newman to speak at 2025 JP Morgan Industrials Conference

Mutual Funds

DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

Comments

ATI

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL